Caxton Associates (UK)’s Enovis ENOV Stock Holding History
Bought
Maintained
Sold
Other funds holding ENOV
RCMNY
DC
HRCM
Caxton Associates (UK)'s ENOV Position: Q2 2026 in Review
Caxton Associates (UK) sold out of Enovis (ENOV) in Q2 2026, closing a stake of 12,884 shares — an estimated $293K sold.
Caxton Associates (UK) first reported a position in ENOV in Q4 2025 and held it in 2 quarters. The position peaked at $293K in Q1 2026. 254 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.
- Caxton Associates (UK) reported no remaining Enovis position as of Q2 2026 after selling out during the quarter.
- Caxton Associates (UK) sold 12,884 Enovis shares in Q2 2026, an estimated $293K.
- Caxton Associates (UK) first reported a position in Enovis in Q4 2025 and held it in 2 quarters.
- Caxton Associates (UK)'s Enovis position peaked at $293K in Q1 2026.
- 254 funds tracked by Wall St. Rank held Enovis as of Q2 2026.
Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.